(Q46772401)

English

Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: a dose-escalation study

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: a dose-escalation study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit